Interestingly, NFkB can be activated by hyaluronan, which is enriched at the tumor margin, through engaging the toll-like receptor (TLR) 4 on the surface of CD44+ glioma stem-like cells [64,65]. This evidence concerns the gene NFKB1 and central nervous system cancer.